Chondroitin Sulfate-Modified Liposomes for Targeted Co-Delivery of Doxorubicin and Retinoic Acid to Suppress Breast Cancer Lung Metastasis
Breast cancer treatment remains challenging due to high levels of cell metastasis. Chemotherapy drug combinations can inhibit both tumor growth in situ and metastasis to distant organs. Therefore, here, we developed chondroitin sulfate liposomes (CSLs) as a carrier for the co-delivery of retinoic ac...
Saved in:
Main Authors: | Zhiwei Zhang (Author), Lixin Ma (Author), Jingwen Luo (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Chondroitin Sulfate and Fucosylated Chondroitin Sulfate as Stimulators of Hematopoiesis in Cyclophosphamide-Induced Mice
by: Nadezhda E. Ustyuzhanina, et al.
Published: (2021) -
Hepatoprotective effects of chondroitin sulfate and glucosamine sulfate
by: I. Yu. Torshin, et al.
Published: (2022) -
Chondroitin sulfate-mediated albumin corona nanoparticles for the treatment of breast cancer
by: Tiantian Tan, et al.
Published: (2021) -
In Vitro Evaluation of Aerosol Therapy with Pentamidine-Loaded Liposomes Coated with Chondroitin Sulfate or Heparin for the Treatment of Leishmaniasis
by: Lucía Román-Álamo, et al.
Published: (2023) -
Perioperative pharmacotherapy for endoprosthetics: potential of chondroitin sulfate and glucosamine sulfate
by: I. Yu. Torshin, et al.
Published: (2022)